Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1 3Phase 4 2Phase 3 1Phase 1/2 1

Status

Completed 20Recruiting 12Unknown 7Terminated 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2373INDUSTRY 910NIH 214NETWORK 112OTHER_GOV 20INDIV 4FED 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Recurrence 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Early Stage Lung Cancer (I and II) 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

leucoselect phytosome 1Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Terminated × FED × Clear all
NCT04515004 2026-02-17

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

VA Office of Research and Development

Phase 2 Terminated
6 enrolled 3 charts
Thoracic

Early Stage Lung Cancer (I and II)

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated
10 enrolled 20 charts

Cachexia

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡